NPI: 1700037801 · EVERETT, WA 98201 · General Acute Care Hospital · NPI assigned 10/07/2008
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASST SECRETARY-ENROLLMENT) |
| NPI Enumeration Date | 10/07/2008 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 337,072 | $10.74M |
| 2019 | 338,913 | $10.38M |
| 2020 | 276,662 | $8.19M |
| 2021 | 319,398 | $9.35M |
| 2022 | 283,893 | $9.00M |
| 2023 | 256,124 | $8.00M |
| 2024 | 213,460 | $6.76M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 25,121 | 22,354 | $7.78M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 43,539 | 40,840 | $4.82M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 63,422 | 42,501 | $4.68M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 52,933 | 48,553 | $4.44M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 50,431 | 46,650 | $4.36M |
| 59025 | Fetal non-stress test | 23,753 | 12,062 | $3.79M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 12,416 | 12,009 | $2.03M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 16,104 | 10,246 | $1.98M |
| 70450 | Computed tomography, head or brain; without contrast material | 12,900 | 12,244 | $1.62M |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 5,998 | 4,540 | $1.60M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5,201 | 5,113 | $1.25M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 2,158 | 2,125 | $940K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 28,937 | 24,708 | $915K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1,703 | 1,678 | $855K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 8,299 | 7,677 | $845K |
| 77412 | 1,568 | 153 | $765K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 10,389 | 10,281 | $699K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 4,323 | 4,176 | $643K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 6,987 | 6,753 | $628K |
| 29581 | 3,687 | 1,140 | $570K | |
| 76830 | Ultrasound, transvaginal | 6,506 | 6,367 | $560K |
| 70496 | 3,218 | 3,103 | $553K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,249 | 3,179 | $539K |
| 76642 | 6,538 | 5,818 | $535K | |
| 76801 | 8,505 | 7,718 | $525K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7,702 | 6,987 | $521K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,884 | 1,853 | $451K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,557 | 3,398 | $446K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,376 | 5,209 | $410K |
| 80053 | Comprehensive metabolic panel | 87,722 | 76,405 | $398K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 266 | 264 | $383K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 6,094 | 4,485 | $347K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 6,175 | 5,603 | $345K |
| 93971 | 3,696 | 3,528 | $343K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1,941 | 1,884 | $328K |
| G0378 | Hospital observation service, per hour | 31,533 | 10,743 | $327K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 2,082 | 2,052 | $325K |
| 71046 | Radiologic examination, chest; 2 views | 13,054 | 12,653 | $314K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 6,945 | 6,898 | $302K |
| 76819 | Fetal biophysical profile; without non-stress testing | 6,492 | 3,248 | $294K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 6,342 | 6,216 | $292K |
| 93017 | 3,011 | 2,944 | $287K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 2,728 | 2,695 | $279K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 4,208 | 4,176 | $267K |
| 12001 | 1,156 | 1,140 | $222K | |
| 76770 | 2,349 | 2,317 | $219K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 6,262 | 5,379 | $198K |
| 76536 | 2,205 | 2,178 | $196K | |
| 93970 | 1,767 | 1,717 | $165K | |
| 84484 | 32,149 | 24,562 | $160K | |
| 77386 | 387 | 38 | $159K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9,110 | 8,518 | $152K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2,584 | 2,499 | $148K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,168 | 2,794 | $138K |
| 76813 | 2,963 | 2,937 | $133K | |
| 41010 | 142 | 136 | $131K | |
| 77336 | 2,407 | 1,100 | $131K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5,602 | 3,009 | $130K |
| 10061 | 671 | 644 | $128K | |
| 77066 | Tomosynthesis, mammo | 4,155 | 4,087 | $118K |
| 47562 | 53 | 53 | $116K | |
| 72100 | 4,879 | 4,808 | $112K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 248 | 244 | $111K |
| 12002 | 585 | 578 | $110K | |
| 93458 | 121 | 119 | $109K | |
| 76870 | 1,158 | 1,122 | $107K | |
| 74174 | 597 | 584 | $105K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 313 | 259 | $105K |
| 95811 | 269 | 267 | $103K | |
| 73562 | 2,942 | 2,867 | $103K | |
| 72141 | 698 | 688 | $99K | |
| 87040 | 13,964 | 7,436 | $91K | |
| 12011 | 434 | 429 | $90K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 20,242 | 16,321 | $88K |
| 77065 | Tomosynthesis, mammo | 2,802 | 2,641 | $87K |
| 76937 | 2,175 | 2,000 | $87K | |
| 73610 | 4,790 | 4,469 | $87K | |
| 73630 | 4,703 | 4,374 | $85K | |
| 73130 | 4,821 | 4,328 | $84K | |
| 73030 | 5,380 | 4,859 | $84K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3,523 | 1,616 | $84K |
| 72040 | 2,654 | 2,603 | $71K | |
| 70498 | 3,424 | 3,299 | $69K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 6,102 | 5,858 | $69K |
| 70491 | 578 | 566 | $68K | |
| 74018 | 3,214 | 3,056 | $68K | |
| 83605 | 13,981 | 12,022 | $67K | |
| 76818 | 1,098 | 524 | $67K | |
| 19083 | 91 | 88 | $65K | |
| 76882 | 916 | 806 | $65K | |
| 58571 | 26 | 26 | $64K | |
| 73110 | 3,455 | 3,173 | $63K | |
| 70486 | 2,289 | 2,241 | $62K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 220 | 215 | $59K |
| 71250 | 1,132 | 1,109 | $57K | |
| 73140 | 2,050 | 1,968 | $57K | |
| 97162 | 1,814 | 1,738 | $55K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 6,244 | 6,203 | $53K |
| J1756 | Injection, iron sucrose, 1 mg | 2,053 | 898 | $53K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 3,346 | 3,263 | $52K |
| 90715 | 2,818 | 2,764 | $50K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 40,381 | 34,610 | $50K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 51,098 | 45,782 | $50K |
| 73502 | 2,925 | 2,833 | $45K | |
| 64483 | 95 | 94 | $45K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 6,279 | 4,380 | $43K |
| 83880 | 7,847 | 7,272 | $41K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 6,416 | 6,213 | $41K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 214 | 174 | $39K |
| 29848 | 28 | 28 | $37K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,314 | 3,249 | $37K |
| 77334 | 123 | 96 | $37K | |
| 36415 | Collection of venous blood by venipuncture | 51,096 | 37,924 | $36K |
| 97116 | 2,457 | 1,431 | $36K | |
| D2330 | 61 | 60 | $35K | |
| 10060 | 159 | 155 | $35K | |
| 71045 | Radiologic examination, chest; single view | 32,719 | 30,169 | $34K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 1,746 | 1,216 | $34K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,476 | 2,409 | $33K |
| 73560 | 1,702 | 1,626 | $32K | |
| 36430 | 747 | 569 | $32K | |
| 87631 | 1,562 | 1,542 | $31K | |
| 72131 | 858 | 827 | $29K | |
| 85379 | 5,336 | 5,199 | $28K | |
| 58661 | 12 | 12 | $27K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 82,779 | 72,259 | $27K |
| 97165 | 775 | 744 | $26K | |
| 36902 | 39 | 38 | $25K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 177 | 170 | $25K |
| 93880 | 495 | 487 | $24K | |
| 73590 | 1,990 | 1,788 | $24K | |
| J1644 | Injection, heparin sodium, per 1000 units | 14,294 | 6,320 | $23K |
| 87510 | 3,120 | 3,003 | $23K | |
| 58671 | 12 | 12 | $22K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 37 | 37 | $22K |
| 73080 | 1,673 | 1,580 | $22K | |
| 77290 | 89 | 71 | $22K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 66 | 66 | $22K |
| 73564 | 3,021 | 2,674 | $22K | |
| 36561 | 24 | 24 | $21K | |
| 97166 | 777 | 745 | $19K | |
| 54161 | 15 | 15 | $19K | |
| 29125 | 86 | 86 | $19K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 105 | 104 | $19K |
| 85027 | 26,071 | 22,451 | $19K | |
| 84112 | 2,473 | 2,197 | $19K | |
| 97535 | Self-care/home management training, each 15 minutes | 1,429 | 1,083 | $18K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,005 | 584 | $17K |
| 94770 | 225 | 213 | $17K | |
| 84145 | 1,641 | 1,549 | $17K | |
| 96367 | 683 | 599 | $17K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,594 | 1,511 | $17K |
| 73090 | 1,431 | 1,283 | $16K | |
| 87660 | 3,119 | 3,002 | $16K | |
| 97161 | 533 | 517 | $16K | |
| 93922 | 325 | 320 | $15K | |
| 58558 | 12 | 12 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 27,388 | 23,490 | $13K |
| 71271 | 130 | 130 | $12K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 200 | 198 | $12K |
| 62323 | 47 | 47 | $12K | |
| 77280 | 65 | 56 | $12K | |
| 88307 | 662 | 648 | $11K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,386 | 1,364 | $11K |
| 93325 | 162 | 156 | $9K | |
| 86850 | 5,850 | 5,494 | $9K | |
| 86900 | 7,791 | 6,222 | $9K | |
| 94726 | 327 | 324 | $8K | |
| 71101 | 614 | 599 | $8K | |
| 94729 | 414 | 409 | $8K | |
| 72072 | 563 | 554 | $8K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 248 | 106 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 13,637 | 10,514 | $8K |
| 72170 | 1,657 | 1,588 | $8K | |
| 80061 | Lipid panel | 1,761 | 1,711 | $7K |
| 84703 | 18,409 | 17,352 | $7K | |
| 81001 | 48,358 | 44,363 | $7K | |
| 73660 | 257 | 249 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,085 | 3,019 | $7K |
| D2332 | 14 | 14 | $7K | |
| 72070 | 248 | 247 | $7K | |
| 80143 | 710 | 662 | $7K | |
| 83735 | 10,655 | 9,014 | $6K | |
| 72110 | 172 | 170 | $6K | |
| 94060 | 154 | 152 | $6K | |
| C8908 | Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral | 25 | 25 | $6K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 60 | 44 | $6K |
| 74019 | 230 | 228 | $6K | |
| P9047 | Infusion, albumin (human), 25%, 50 ml | 15 | 12 | $5K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 136 | 136 | $5K |
| 84702 | 5,986 | 5,514 | $5K | |
| 86901 | 8,708 | 7,060 | $5K | |
| 86923 | 434 | 371 | $5K | |
| 0001A | 138 | 131 | $5K | |
| 97597 | 104 | 92 | $5K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 115 | 99 | $5K |
| 95819 | 39 | 39 | $5K | |
| 93308 | 31 | 28 | $5K | |
| 83690 | 25,496 | 23,513 | $4K | |
| 80179 | 2,066 | 1,970 | $4K | |
| 85610 | 43,178 | 31,356 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | 4,717 | 4,525 | $4K |
| 74183 | 13 | 13 | $4K | |
| G0249 | Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests | 148 | 136 | $4K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 12 | 12 | $4K |
| 93990 | 93 | 89 | $4K | |
| 80164 | 500 | 440 | $3K | |
| 77049 | 16 | 15 | $3K | |
| 73552 | 343 | 312 | $3K | |
| 87081 | 2,115 | 1,852 | $3K | |
| 70487 | 25 | 25 | $3K | |
| 83050 | 491 | 454 | $3K | |
| 82075 | 5,596 | 4,942 | $3K | |
| 93925 | 39 | 38 | $3K | |
| 72158 | 27 | 26 | $3K | |
| 72197 | 12 | 12 | $3K | |
| 86140 | 3,941 | 3,422 | $3K | |
| 82565 | 3,043 | 2,758 | $3K | |
| 96376 | 10,330 | 8,512 | $3K | |
| 29515 | 12 | 12 | $3K | |
| J1750 | Injection, iron dextran, 50 mg | 73 | 38 | $3K |
| 75574 | 12 | 12 | $3K | |
| 82247 | 5,263 | 4,162 | $3K | |
| 84163 | 216 | 216 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,476 | 2,409 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,808 | 6,457 | $2K |
| 82962 | 12,031 | 6,558 | $2K | |
| 77307 | 12 | 12 | $2K | |
| 77002 | 17 | 17 | $2K | |
| 72128 | 179 | 171 | $2K | |
| Q3014 | Telehealth originating site facility fee | 86 | 84 | $2K |
| 77300 | 53 | 50 | $2K | |
| 73120 | 71 | 58 | $2K | |
| 82550 | 2,857 | 2,232 | $2K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 8,205 | 7,949 | $2K |
| 80050 | General health panel | 575 | 567 | $2K |
| 96368 | 14 | 12 | $2K | |
| 73620 | 71 | 64 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,195 | 3,127 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 34,507 | 27,645 | $2K |
| 87070 | 2,874 | 2,612 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | 31,441 | 17,885 | $2K |
| 93926 | 26 | 25 | $2K | |
| 82077 | 4,505 | 4,083 | $2K | |
| 81025 | 6,364 | 6,161 | $2K | |
| 85014 | 4,027 | 3,168 | $2K | |
| 99381 | 24 | 24 | $2K | |
| 93321 | 13 | 13 | $2K | |
| 97163 | 57 | 52 | $2K | |
| 82570 | 1,910 | 1,697 | $2K | |
| 76820 | 63 | 37 | $2K | |
| 87480 | 3,120 | 3,003 | $2K | |
| 73070 | 69 | 64 | $1K | |
| 93797 | 180 | 26 | $1K | |
| 76942 | 53 | 50 | $1K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 3,086 | 2,937 | $1K |
| 87075 | 1,265 | 1,114 | $1K | |
| 73522 | 64 | 64 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 22,421 | 18,788 | $1K |
| 84466 | 583 | 563 | $1K | |
| 97035 | 252 | 130 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 13,121 | 9,553 | $1K |
| 99152 | 3,408 | 3,237 | $1K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 12 | 12 | $1K |
| J3490 | Unclassified drugs | 3,155 | 2,927 | $1K |
| 73100 | 32 | 30 | $1K | |
| 82607 | 398 | 390 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 20,662 | 16,665 | $1K |
| 85018 | 3,780 | 3,004 | $1K | |
| 80178 | 151 | 133 | $1K | |
| 82731 | 98 | 94 | $1K | |
| 93350 | 14 | 13 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 14,714 | 12,314 | $1K |
| 84156 | 2,063 | 1,647 | $1K | |
| A9270 | Non-covered item or service | 23,762 | 4,555 | $1K |
| 90686 | 122 | 122 | $998.20 | |
| 87186 | 3,100 | 2,977 | $998.05 | |
| J2704 | Injection, propofol, 10 mg | 12,783 | 12,182 | $966.27 |
| 73060 | 135 | 126 | $958.59 | |
| 93976 | 12 | 12 | $955.19 | |
| 80076 | 268 | 257 | $942.24 | |
| 87077 | 3,096 | 2,961 | $880.18 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 12 | 12 | $875.83 |
| 74022 | 243 | 236 | $865.16 | |
| 99153 | Mod sedat endo service >5yrs | 3,251 | 3,087 | $861.39 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,811 | 8,272 | $859.99 |
| J7030 | Infusion, normal saline solution , 1000 cc | 24,443 | 20,874 | $843.94 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 11,855 | 7,638 | $798.30 |
| 87506 | 12 | 12 | $793.94 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 359 | 334 | $788.77 |
| G0379 | Direct admission of patient for hospital observation care | 105 | 103 | $783.17 |
| 87205 | 3,197 | 2,826 | $777.18 | |
| 73600 | 27 | 26 | $756.62 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 13,731 | 12,741 | $742.89 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,530 | 3,354 | $725.13 |
| 87147 | 1,394 | 1,322 | $691.37 | |
| 73700 | 14 | 12 | $642.33 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 2,511 | 2,249 | $633.75 |
| 83540 | 655 | 626 | $631.71 | |
| 36591 | 381 | 308 | $626.67 | |
| 85651 | 1,665 | 1,450 | $622.09 | |
| 84439 | 549 | 517 | $621.10 | |
| C1769 | Guide wire | 3,625 | 3,415 | $574.59 |
| 82728 | 339 | 329 | $569.16 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 26,153 | 24,834 | $568.14 |
| 84550 | 1,285 | 1,074 | $560.78 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 12,840 | 10,269 | $550.94 |
| J2785 | Injection, regadenoson, 0.1 mg | 1,549 | 1,519 | $539.00 |
| 85049 | 964 | 795 | $514.67 | |
| 77012 | 12 | 12 | $453.78 | |
| 85652 | 1,096 | 936 | $444.27 | |
| 85730 | 2,965 | 2,791 | $442.46 | |
| 81003 | 3,710 | 3,610 | $439.18 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3,087 | 2,747 | $439.18 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 77 | 52 | $416.67 |
| 72220 | 24 | 24 | $409.44 | |
| 97803 | 30 | 20 | $403.78 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 10,444 | 8,619 | $403.29 |
| 90839 | 3,872 | 3,585 | $400.17 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 4,531 | 4,390 | $399.40 |
| 0004A | 12 | 12 | $376.80 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 10,595 | 7,537 | $365.57 |
| 84100 | 1,174 | 1,054 | $362.73 | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 51 | 51 | $357.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 517 | 504 | $356.37 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5,792 | 5,244 | $298.12 |
| 80069 | 79 | 70 | $294.20 | |
| A4648 | Tissue marker, implantable, any type, each | 650 | 551 | $293.25 |
| 82805 | 728 | 682 | $291.38 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 7,640 | 3,008 | $287.84 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 239 | 234 | $286.70 |
| 84450 | 1,035 | 850 | $284.21 | |
| 94644 | 123 | 119 | $280.87 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 5,109 | 4,575 | $271.55 |
| J3370 | Injection, vancomycin hcl, 500 mg | 5,008 | 2,639 | $268.11 |
| 94150 | 29 | 27 | $266.83 | |
| 88304 | 689 | 681 | $265.14 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,923 | 1,705 | $258.93 |
| 72020 | 32 | 27 | $247.72 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 1,130 | 997 | $223.71 |
| 88342 | 1,198 | 1,159 | $209.82 | |
| 89051 | 571 | 458 | $209.71 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 4,563 | 4,004 | $169.44 |
| 87340 | 143 | 137 | $162.67 | |
| 86336 | 255 | 255 | $151.05 | |
| 82553 | 30 | 28 | $143.63 | |
| 82272 | 794 | 772 | $128.29 | |
| 0353U | 530 | 511 | $127.14 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 5,309 | 5,039 | $115.03 |
| 70360 | 13 | 12 | $112.74 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 3,661 | 3,580 | $111.44 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2,518 | 2,300 | $106.49 |
| 81005 | 192 | 186 | $105.15 | |
| 88341 | 575 | 560 | $97.78 | |
| J1815 | Injection, insulin, per 5 units | 9,494 | 3,942 | $96.11 |
| J1790 | Injection, droperidol, up to 5 mg | 1,375 | 1,236 | $94.22 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 221 | 170 | $82.27 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 326 | 322 | $81.37 |
| 82010 | 1,459 | 1,356 | $81.18 | |
| 83986 | 183 | 162 | $80.31 | |
| 85576 | 180 | 170 | $77.28 | |
| J1953 | Injection, levetiracetam, 10 mg | 126 | 101 | $74.21 |
| 82248 | 97 | 88 | $66.26 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 3,983 | 3,449 | $65.81 |
| J2060 | Injection, lorazepam, 2 mg | 7,459 | 6,079 | $64.62 |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 630 | 572 | $64.50 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,420 | 1,995 | $60.07 |
| 82803 | 326 | 269 | $57.17 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 2,712 | 2,514 | $55.16 |
| 87493 | 98 | 92 | $50.03 | |
| 85384 | 455 | 422 | $49.39 | |
| C1788 | Port, indwelling (implantable) | 24 | 24 | $43.14 |
| 84132 | 171 | 147 | $42.03 | |
| 86780 | 37 | 37 | $41.03 | |
| 82375 | 318 | 296 | $34.03 | |
| 88108 | 209 | 158 | $33.87 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 3,995 | 1,499 | $31.74 |
| 87088 | 221 | 208 | $31.41 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 2,319 | 1,900 | $26.47 |
| 82140 | 144 | 135 | $24.38 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 893 | 368 | $19.28 |
| 96040 | 1,140 | 1,128 | $18.54 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,223 | 1,187 | $17.05 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 446 | 335 | $16.14 |
| 87149 | 84 | 50 | $14.57 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 1,041 | 870 | $12.64 |
| J3480 | Injection, potassium chloride, per 2 meq | 1,531 | 1,217 | $12.40 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 343 | 314 | $11.59 |
| 86706 | 14 | 13 | $11.20 | |
| 87899 | 17 | 15 | $10.95 | |
| J1630 | Injection, haloperidol, up to 5 mg | 1,930 | 1,699 | $9.55 |
| C9113 | Injection, pantoprazole sodium, per vial | 1,524 | 911 | $8.93 |
| 87045 | 15 | 15 | $8.82 | |
| 36600 | 117 | 111 | $8.21 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 593 | 569 | $7.73 |
| J1940 | Injection, furosemide, up to 20 mg | 1,596 | 1,078 | $6.78 |
| J3411 | Injection, thiamine hcl, 100 mg | 985 | 747 | $5.88 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 97 | 95 | $5.39 |
| 85347 | 595 | 465 | $5.06 | |
| 87046 | 15 | 15 | $4.41 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 3,378 | 2,376 | $3.63 |
| 88311 | 13 | 13 | $2.43 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 2,182 | 1,561 | $1.18 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 437 | 411 | $1.08 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 754 | 402 | $1.02 |
| J3415 | Injection, pyridoxine hcl, 100 mg | 83 | 78 | $0.56 |
| J0456 | Injection, azithromycin, 500 mg | 37 | 27 | $0.49 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 22,986 | 20,624 | $0.01 |
| C1729 | Catheter, drainage | 51 | 44 | $0.00 |
| 84295 | 30 | 28 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 176 | 155 | $0.00 |
| D1120 | Prophylaxis - child | 273 | 266 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 431 | 368 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 304 | 300 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 420 | 357 | $0.00 |
| 0042T | 80 | 78 | $0.00 | |
| C1760 | Closure device, vascular (implantable/insertable) | 45 | 40 | $0.00 |
| C1876 | Stent, non-coated/non-covered, with delivery system | 30 | 30 | $0.00 |
| 51702 | 29 | 26 | $0.00 | |
| C1758 | Catheter, ureteral | 50 | 49 | $0.00 |
| G0390 | Trauma response team associated with hospital critical care service | 13 | 13 | $0.00 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 13 | 12 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 24 | 24 | $0.00 |
| 82947 | 27 | 26 | $0.00 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 49 | 48 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 236 | 169 | $0.00 |
| 87641 | 26 | 25 | $0.00 | |
| C1776 | Joint device (implantable) | 12 | 12 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 154 | 126 | $0.00 |
| 85390 | 178 | 168 | $0.00 | |
| C1889 | Implantable/insertable device, not otherwise classified | 154 | 152 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 791 | 708 | $0.00 |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 161 | 160 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 119 | 109 | $0.00 |
| D0240 | 295 | 288 | $0.00 | |
| D0272 | Bitewings - two radiographic images | 297 | 290 | $0.00 |
| 0240U | 740 | 720 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 1,527 | 1,098 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 536 | 397 | $0.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 14 | 12 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 15 | 15 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 124 | 86 | $0.00 |
| S9981 | Medical records copying fee, administrative | 15 | 15 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 25 | 25 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 221 | 209 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 101 | 94 | $0.00 |
| D0150 | Comprehensive oral evaluation - new or established patient | 95 | 94 | $0.00 |
| C1781 | Mesh (implantable) | 127 | 126 | $0.00 |
| 82435 | 29 | 28 | $0.00 | |
| L8699 | Prosthetic implant, not otherwise specified | 16 | 15 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 35 | 26 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 29 | 29 | $0.00 |
| J0280 | Injection, aminophyllin, up to 250 mg | 29 | 29 | $0.00 |
| S9982 | Medical records copying fee, per page | 15 | 15 | $0.00 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 40 | 25 | $0.00 |
| 82330 | 30 | 28 | $0.00 | |
| J2305 | Injection, nitroglycerin, 5 mg | 15 | 14 | $0.00 |
| 51798 | 13 | 13 | $0.00 | |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | 17 | 12 | $0.00 |